» Articles » PMID: 37228574

Are Calcium Channel Blockers Related to Lung Cancer?

Overview
Specialty Pharmacology
Date 2023 May 25
PMID 37228574
Authors
Affiliations
Soon will be listed here.
References
1.
Scragg R, Glover M . Parental and adolescent smoking: does the association vary with gender and ethnicity?. N Z Med J. 2007; 120(1267):U2862. View

2.
Manasirisuk P, Chainirun N, Tiamkao S, Lertsinudom S, Phunikhom K, Sawunyavisuth B . Efficacy of Generic Atorvastatin in a Real-World Setting. Clin Pharmacol. 2021; 13:45-51. PMC: 7943322. DOI: 10.2147/CPAA.S285750. View

3.
Jick H, Jick S, Derby L, Vasilakis C, Myers M, Meier C . Calcium-channel blockers and risk of cancer. Lancet. 1997; 349(9051):525-8. DOI: 10.1016/S0140-6736(97)80084-0. View

4.
Cote M, Liu M, Bonassi S, Neri M, Schwartz A, Christiani D . Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012; 48(13):1957-68. PMC: 3445438. DOI: 10.1016/j.ejca.2012.01.038. View

5.
Michels K, Rosner B, Walker A, Stampfer M, Manson J, Colditz G . Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer. 1998; 83(9):2003-7. View